The researchers used a decision-tree model to compare the clinical and economic consequences of fidaxomicin [Dificid] 200mg every12h with those of vancomycin [Vancocin] 125mg every 6h, for 10days, for the treatment of severe CDI from the perspective of the Canadian healthcare system. The study...